Tamoxifen in advanced prostatic carcinom
✍
Frank M. Torti; Bert L. Lum; Richard Lo; Fuad Freiha; Linda Shortliffe
📂
Article
📅
1984
🏛
John Wiley and Sons
🌐
English
⚖ 431 KB
👁 2 views
Patients with advanced prostatic carcinoma who had received minimal or no prior therapy were treated with tamoxifen citrate in escalating doses from 10 to 50 mg orally twice a day. Twenty-nine courses were evaluated in 17 patients. Entry was limited to patients with measurable sites of disease. Ther